Panel Discussion: The HER2 Expression Levels Debate: HER2 High vs HER2 Low
Time: 11:30 am
day: Day One
Details:
• Progress towards an improved standard of HER2 expression definition
• Exploring the IHC & FISH standardization and improvement
• Understanding different requirements for expression measurement for various indications
• How does HER2 expression compare across indications?
• How does that compare for a therapeutic in terms of defining illegibility criteria?
• How to define non-HER2 positive?
• Standardizing the approach of measurement in the labs – addressing variation and variability between sample
